Shoulder Innovations, Inc. (SI)
NYSE
Healthcare
Medical - Specialties
$16.99
▼ -0.12%
Market Cap
$352.3M
Sector
Healthcare
Industry
Medical - Specialties
Beta
-1.77
52-Wk Range
10.92-24.6
CEO
Robert Joseph Ball
Country
US
Currency
USD
Shoulder Innovations, Inc. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Grand Rapids, MI, US. The stock last traded at $16.99, down 0.12% on the session, giving a market capitalisation of $352.3M. On trailing twelve-month figures it carries a trailing P/E of -9.94, a net margin of -58.3%. Its beta of -1.77 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
-9.94
Price / Sales
5.87
Price / Book
2.83
EV / EBITDA
-10.38
Gross margin
77.3%
Operating margin
-58.5%
Net margin
-58.3%
Return on equity
—
Debt / equity
0.12
Current ratio
10.71
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange
Employees
74
IPO date
2025-07-31
Headquarters
Grand Rapids, MI, US
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Comparable companies
Shoulder Innovations, Inc. is most often compared with the following Healthcare names:
More research on SI
Open full interactive analysis & DCF →